Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Warmer countries less vulnerable to COVID-19, study finds

In fact, a new study by a researcher at the University College London (UCL) suggests that global temperature plays an essential role in the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19.

29 Nov 2020

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Now, a surprising new study shows that asymptomatic COVID-19 patients have greater viral loads than those with symptoms.

29 Nov 2020

Research suggests importance of vitamin D for good health in the context of COVID-19

A researcher at the UNC Nutrition Research Institute, University of North Carolina revealed that avoiding vitamin D deficiency may help reduce the risk of severe COVID-19.

29 Nov 2020

MARA project aims to use new DNA based nanotechnology to fight bacteria

Antibiotics are used to prevent and treat bacterial infections. They have played a major role in combating infectious diseases such as tuberculosis, pneumonia, typhoid fever, and meningitis in 20th century.

27 Nov 2020

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

A recent study reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the viral replication SARS-CoV-2.

27 Nov 2020

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

A new study reports a very promising anti-SARS-CoV-2 monoclonal antibody, HB27, that appears to have two distinct mechanisms of action inhibiting the virus-host cell interaction and subsequent infection.

27 Nov 2020

Could beta-blockers be a potential treatment for COVID-19?

News-Medical spoke to researchers about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19.

27 Nov 2020

Salient Bio launches robotics driven COVID-19 mass testing platform

UK diagnostics firm Salient Bio has announced the commercial roll out of its robotics driven COVID-19 mass testing platform.

27 Nov 2020

Immunonutrition may improve COVID-19 patients' recovery

Researchers duo Emma Derbyshire and Joanne Delange from the Nutritional Insight, Surrey, United Kingdom, explore the role of immunonutrition – nutrition that boosts or influences the immune system for those over 65 years of age in COVID-19. Their study titled, “COVID-19: is there a role for immunonutrition, particularly in the over 65s?,” was released in the latest issue of the BMJ Nutrition, Prevention and Health.

26 Nov 2020

Transgenic mouse model could recapitulate severe COVID-19 in humans

Researchers in the United States and Canada have described the potential for a transgenic mouse model to serve as an effective platform for the study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease course in humans.

26 Nov 2020

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

A team of researchers at the Robert Wood Johnson Medical School, Rutgers University, USA, have investigated a case wherein a man experienced recurrent episodes of Guillain–Barré Syndrome after being infected with SARS-CoV-2.

26 Nov 2020

SARS-CoV-2 immunity can sustain for at least eight months, study finds

A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.

26 Nov 2020

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

A shorter genome comprising only a part of the SARS-CoV-2's RNA genome competes with the normal virus for growth and can potentially prevent viral replication.

26 Nov 2020

Study shows lower light pollution during COVID-19 lockdown in Granada

A novel study reports a favorable change in light pollution during the lockdown in Granada, Spain, from March to May 2020, and has traced it back to several different causes related to COVID-19 lockdown measures.

26 Nov 2020

Early interferon therapy may mitigate COVID-19 severity

A recent review of COVID-19 therapies explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve further development.

26 Nov 2020

Early use of existing treatment helps save hospitalized COVID-19 patients

The lives of patients hospitalized with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.

25 Nov 2020

Lungs of COVID-19 patients show good recovery in most cases

Lung tissue of patients who suffered severely from COVID-19 shows good recovery in most cases. This was revealed by a study carried out by the Radboud university medical center that has now been published in Clinical Infectious Diseases.

25 Nov 2020

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

A team of scientists from South Korea and the United States has conducted an interesting study to investigate whether mutations in the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect the severity of coronavirus disease 2019 (COVID-19). The study findings reveal that mutations in the viral spike protein and RNA polymerase complex can increase the risk of COVID-19 mortality.

25 Nov 2020

Study sheds new light on genetic risk factors that make individuals susceptible to severe COVID-19

Even as tens of thousands of Americans test positive for COVID-19 each day, physicians still aren't sure why some people experience mild to no symptoms while others become critically ill.

25 Nov 2020

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

In a recent cutting-edge study, US researchers unveiled an anti-staphylococcal enterotoxin B monoclonal antibody that can be repurposed to target the cleavage site of the SARS-CoV-2 spike glycoprotein and, in turn, inhibit viral infection. Their findings are currently available on bioRxiv preprint server.

25 Nov 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Warmer countries less vulnerable to COVID-19, study finds

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Research suggests importance of vitamin D for good health in the context of COVID-19

MARA project aims to use new DNA based nanotechnology to fight bacteria

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

Could beta-blockers be a potential treatment for COVID-19?

Salient Bio launches robotics driven COVID-19 mass testing platform

Immunonutrition may improve COVID-19 patients' recovery

Transgenic mouse model could recapitulate severe COVID-19 in humans

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

SARS-CoV-2 immunity can sustain for at least eight months, study finds

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

Study shows lower light pollution during COVID-19 lockdown in Granada

Early interferon therapy may mitigate COVID-19 severity

Early use of existing treatment helps save hospitalized COVID-19 patients

Lungs of COVID-19 patients show good recovery in most cases

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

Study sheds new light on genetic risk factors that make individuals susceptible to severe COVID-19

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Newsletters you may be interested in